We used the transplantable TRAMP-C2 prostate carcinoma cell model, as the rate of tumor growth is slow enough to allow for investigation of memory CD8+ T cells several weeks following tumor inoculation, and the tumors are known to be responsive to ICI treatment35. The gene discussed is CD8A; the disease is prostate carcinoma.